Results

Total Results: 1,887 records

Showing results for "testing".

1. Prenatal Testing | Effective Health Care (EHC) Program
   effectivehealthcare.ahrq.gov/health-topics/prenatal-testing

2. Genetic Testing | Effective Health Care (EHC) Program
   effectivehealthcare.ahrq.gov/health-topics/genetic-testing

3. Hepatitis Testing | Effective Health Care (EHC) Program
   effectivehealthcare.ahrq.gov/health-topics/hepatitis-testing

4. Noninvasive Testing for Coronary Artery Disease (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/pdf/coronary-artery-disease-testing_research-protocol.pdf
   January 15, 2015 - Some types of noninvasive testing (e.g., stress testing) provide additional information not provided … , imaging stress testing, or no further testing? … or no further testing … (both initial and subsequent testing) • Harms of testing (renal failure, allergy, nephrogenic systemic … Consequences of testing may also include use of downstream testing, anxiety related to false positives

5. genetic-testing-developmental-disabilities-protocol-140930 (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/pdf/genetic-testing-developmental-disabilities_research-protocol.pdf
   September 30, 2014 - genetic-testing-developmental-disabilities-protocol-140930 … , 4 19,120-122 use of the testing in practice, or patient section for testing Narrative reviews 21 … Topic triage cover sheet: Genetic testing for developmental diseases. … Clinical genetic testing for patients with autism spectrum disorders. … Genetic Testing and Molecular Biomarkers. 2012 Mar 1;16(3):187-92.

6. Additional Patient Outcomes and Alternative Pathways in Evaluations of Testing | Effective Health Care (EHC) Program
   effectivehealthcare.ahrq.gov/products/outcomes-testing-evaluation/research

7. For women, when comparing noninvasive testing,which testing method (echocardiography, MIBI-SPECT, pharmacological testing, etc.) is more accurate in diagnosing coronary artery disease. There has been inadequate studies done on women for… | Effective Health Care (EHC) Program
   effectivehealthcare.ahrq.gov/get-involved/nominated-topics/for-women-when-comparing-noninvasive-testingwhich-testing-method-echocardiography-mibi-spect-pharmacological-testing-etc-is-more-accurate-in-diagnosing-coronary-artery-disease-there-has-been-inadequate-studies-done-on-women-

8. Development and Usability Testing of EPC Evidence Review Dissemination Summaries for Health Systems Decisionmakers | Effective Health Care (EHC) Program
   effectivehealthcare.ahrq.gov/products/usability-testing/methods-report

9. Topic 0505 Genetic Testing for Developmental Diseases NSD FINAL_SJ (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0594-131115.pdf
   March 13, 2013 - Topic 0505 Genetic Testing for Developmental Diseases NSD FINAL_SJ … § Genetic Testing for Developmental Diseases Nomination Summary Document … Results of Topic Selection Process & Next Steps  The topic, Genetic Testing … Comparator(s): Other genetic testing/no genetic testing Outcome(s): Changes to child treatment specific …  Given the limited available evidence, the rapid pace of change in genetic testing, and the recent

10. Disposition of Comments for Technical Brief 23 Genetic Testing (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/genetic-testing-developmental-disabilities_disposition-comments.pdf
    June 30, 2015 - Testing in these two situations should be looked at separately. … when compared with no testing. … that no testing for any underlying diagnosis is worthwhile. … They may do focused/targeted aCGH/microarray testing. … Good example of potential risk of testing?

11. Quantitative Synthesis: Chapter 4. Quantifying, Testing, and Exploring Statistical Heterogeneity (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/ehc-presentation-quantitative-synthesis-chapter-4.pdf
    July 01, 2019 - Quantifying, Testing, and Exploring Statistical Heterogeneity Quantitative Synthesis Chapter 4. … Quantifying, Testing, and Exploring Statistical Heterogeneity Prepared for: The Agency for Healthcare … incorporate the subgroup factor into a meta-regression framework.20 − This enables formal statistical testing … , allows for quantification of heterogeneity and testing for residual heterogeneity. 20. … Quantifying, Testing, and Exploring �Statistical Heterogeneity Learning objective Statistical heterogeneity

12. Data Points 15: Breast Cancer Diagnostic Workup: Prognostic factor testing among older women with ductal carcinoma in situ and early invasive breast cancer (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/dcis-prognostic-tests_research.pdf
    August 22, 2012 - Estrogen and Progesterone Receptor Testing Rates of ER/PR testing for women with DCIS varied strongly … HER2 Testing As with ER/PR testing, HER2 testing increased dramati- cally among women with DCIS between … BRCA Testing We found a low rate (0.6%) of BRCA testing among women with DCIS. … and are thus testing randomly. … Data Points • # 15 • Breast Cancer Diagnostic Workup 14 Appendix D: ER/PR testing and HER2 testing

13. Cancer Quality-ASSIST Supportive Oncology Quality Indicator Set: Feasibility, Reliability, and Validity Testing | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/cancer-quality-indicator-testing/research

14. Noninvasive Testing for Coronary Artery Disease | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/coronary-artery-disease-testing/research

15. Executive Summary CER 171: Noninvasive Testing for Coronary Artery Disease (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/coronary-artery-disease-testing_executive.pdf
    March 01, 2011 - Additional Noninvasive Testing Additional noninvasive testing, which impacts the cost and efficiency … Harms and Consequences of Testing Harms of testing were rarely reported and details on comparisons of … No studies that compared testing with an arm that received no testing were identified, so the impact … Studies comparing testing versus clinical evaluation without testing would provide valuable information … for assessing the need for testing, possible overuse of testing, and the impact of testing in general

16. 13-MDM347013 30..38 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/outcomes-testing-evaluation_research.pdf
    January 01, 2009 - Some effects from testing are direct. … A study of genetic testing for BRCA1 and BRCA2 found that women testing positive for a mutation reported … Behavioral Effects of Testing The emotional, social, and cognitive effects of testing may also affect … In this, testing is no exception. … Most of these frameworks look at determinants of testing, however, not at the effects of testing.

17. 13-MDM347013 30..38 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/whitepaper4-bossuyt02262010-2.pdf
    January 01, 2009 - Some effects from testing are direct. … A study of genetic testing for BRCA1 and BRCA2 found that women testing positive for a mutation reported … Behavioral Effects of Testing The emotional, social, and cognitive effects of testing may also affect … In this, testing is no exception. … Most of these frameworks look at determinants of testing, however, not at the effects of testing.

18. Effective Health Care (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0334_08-04-2010.pdf
    January 01, 2010 - Date: 3-22-11 1 Results of Topic Selection Process & Next Steps  Pharmacogenetic testing … Intervention(s): Genetic testing for CYP2C19 variants to guide treatment selection. … Comparator(s): A no-testing (for CYP2C19 variants) strategy or a strategy of testing for Pharmacogenetic … who are candidates for clopidogrel treatment, compared to alternative testing strategies or a no-testing … strategies or a no- testing strategy?

19. PCA3 Testing in the Diagnosis and Management of Prostate Cancer: Future Research Needs (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/prostate-cancer-antigen-3-gene_research.pdf
    April 01, 2013 - Patients with elevated PCA3 values PCA3 testing Current standard of care without PCA3 testing … aggressive therapy PCA3 testing Current standard of care without PCA3 testing Decision to biopsy … Patients with elevated PCA3 values PCA3 testing Current standard of care without PCA3 testing … or standard testing alone. … or standard testing alone.

20. Genetic Testing for Developmental Disabilities, Intellectual Disability, and Autism Spectrum Disorder | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/genetic-testing-developmental-disabilities/technical-brief